Sale!

LONP1 Gene CODAS Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LONP1 gene CODAS syndrome genetic test is a specialized diagnostic tool used to detect mutations in the LONP1 gene, which are associated with CODAS syndrome. CODAS syndrome is a rare genetic disorder characterized by cerebral, ocular, dental, auricular, and skeletal anomalies. This comprehensive test is aimed at individuals who present symptoms of the syndrome or have a family history of genetic disorders, providing crucial information for accurate diagnosis and management.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test ensures high accuracy and reliability. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the LONP1 gene that are indicative of CODAS syndrome.

The cost of the LONP1 gene CODAS syndrome genetic test is 4400 AED. While the price may seem steep, it covers the extensive analysis required to detect the gene mutations accurately. For families and individuals facing the possibility of CODAS syndrome, this test offers invaluable insights, guiding treatment plans and allowing for a better understanding of the condition.

DNA Labs UAE is renowned for its state-of-the-art facilities and expert team, ensuring that patients receive the most accurate and comprehensive genetic testing services available. By choosing to undergo the LONP1 gene CODAS syndrome genetic test at DNA Labs UAE, patients can expect not only top-tier testing technology but also compassionate care and detailed, understandable results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LONP1 Gene CODAS Syndrome Genetic Test

Welcome to DNA Labs UAE, where we offer the LONP1 Gene CODAS Syndrome Genetic Test. This test is designed to diagnose and identify genetic mutations associated with CODAS syndrome, a rare genetic disorder caused by mutations in the LONP1 gene.

Test Details

The LONP1 gene is responsible for producing an enzyme called mitochondrial Lon protease. This enzyme plays a crucial role in maintaining and controlling the quality of mitochondrial proteins. CODAS syndrome, also known as Combined Oxidative Phosphorylation Deficiency 24, is characterized by a variety of symptoms including developmental delay, intellectual disability, muscle weakness, hearing loss, and heart abnormalities.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre-Test Information

Prior to undergoing the LONP1 Gene CODAS Syndrome Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to create a pedigree chart of family members affected by CODAS syndrome. This will help in identifying any potential genetic links and provide a more comprehensive analysis of the patient’s genetic makeup.

NGS Technology

The LONP1 Gene CODAS Syndrome Genetic Test utilizes Next-Generation Sequencing (NGS) technology. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes. By using this advanced technology, our test can detect various genetic mutations or variations associated with CODAS syndrome or other mitochondrial disorders.

Benefits of the Test

The LONP1 Gene CODAS Syndrome Genetic Test can confirm a diagnosis, provide information about the prognosis, and guide appropriate treatment options for individuals suspected of having CODAS syndrome. By identifying specific genetic mutations or variations, this test offers a more comprehensive understanding of the patient’s condition and helps healthcare professionals develop personalized treatment plans.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Our LONP1 Gene CODAS Syndrome Genetic Test is conducted by our experienced team of geneticists and is designed to offer valuable insights into the diagnosis and management of CODAS syndrome. Contact us today to learn more about this test and how it can benefit you or your loved ones.

Test Name LONP1 Gene CODAS syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for LONP1 Gene CODAS syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LONP1 Gene CODAS syndrome NGS Genetic DNA Test gene LONP1
Test Details

The LONP1 gene is a gene that provides instructions for making an enzyme called mitochondrial Lon protease. This enzyme is involved in the maintenance and quality control of mitochondrial proteins.

CODAS syndrome, also known as Combined Oxidative Phosphorylation Deficiency 24, is a rare genetic disorder caused by mutations in the LONP1 gene. It is characterized by a wide range of symptoms including developmental delay, intellectual disability, muscle weakness, hearing loss, and heart abnormalities.

NGS (Next-Generation Sequencing) Genetic Test is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of various genetic mutations or variations in a single test, providing a more comprehensive analysis of an individual’s genetic makeup.

Therefore, an NGS Genetic Test for the LONP1 gene would involve sequencing the gene to identify any mutations or variations that may be associated with CODAS syndrome or other mitochondrial disorders. This test can help in confirming a diagnosis, providing information about the prognosis, and guiding appropriate treatment options for individuals suspected of having CODAS syndrome.